September 24, 2021
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Withholding mycophenolate around the time of vaccination against SARS-CoV-2 proved safe and […]
September 24, 2021
Older age, higher subjective disease activity, and exercising for more than 120 minutes per week were three factors linked to patients with ankylosing spondylitis (AS) who […]
September 23, 2021
The gut microbiome, previously shown to have an association with rheumatoid arthritis, may also provide signals of a patient’s disease prognosis, researchers at the Mayo Clinic […]
September 21, 2021
Interleukin-23 (IL-23) inhibition may still have a role to play in the treatment of patients with axial spondyloarthritis (SpA), suggests research presented at the 12th International […]
September 17, 2021
The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended marketing authorization this week for two new adalimumab biosimilars, Hukyndra and Libmyris. The biosimilars, […]
September 16, 2021
Better retention and remission rates with tumor necrosis factor inhibitors (TNFi) have been observed in patients with spondyloarthritis (SpA) who were also treated with a conventional […]
September 16, 2021
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Patients with rheumatoid arthritis in remission had a rate of flare following […]
September 16, 2021
In the first revision to its guidance on the management of osteoporosis in a decade, The North American Menopause Society (NAMS) has issued an updated position […]
September 16, 2021
Use of cannabidiol (CBD) as an add-on pain management technique in patients with either hand osteoarthritis (OA) or psoriatic arthritis (PsA) did not significantly decrease pain […]